Phase I study of the heparanase inhibitor Roneparstat: an innovative approach for multiple myeloma therapy.

Phase I study of the heparanase inhibitor Roneparstat: an innovative approach for multiple myeloma therapy.
Haematologica. 2018 Apr 26;:
Authors: Galli M, Chatterjee M, Grasso M, Specchia G, Magen H, Einsele H, Celeghini I, Barbieri P, Paoletti D, Pace S, Sanderson RD, Rambaldi A, Nagler A
PMID: 29700168 [PubMed - as supplied by publisher]

Source: Haematologica - April 26, 2018 Category: Hematology Authors: Galli M, Chatterjee M, Grasso M, Specchia G, Magen H, Einsele H, Celeghini I, Barbieri P, Paoletti D, Pace S, Sanderson RD, Rambaldi A, Nagler A Tags: Haematologica Source Type: research